Nitric oxide (NO) holds great promise as a treatment for cancer hypoxia, if its concentration and localization can be precisely controlled. Here, we report a "Trojan Horse" strategy to provide the necessary spatial, temporal, and dosage control of such drug-delivery therapies at targeted tissues. Described is a unique package consisting of (1) a manganese-nitrosyl complex, which is a photoactivated NO-releasing moiety 
Introduction
Nitric oxide (NO) has exhibited signicant potential as a cancer therapy, but its effects are highly concentration-and locationdependent.
1 Furthermore, NO has a relatively short lifetime in physiological media and induces signicant side effects when delivered systemically. 2 Targeting strategies must be a key feature for the delivery of any drug, and this is especially true for a bioregulator such as NO. Photochemical uncaging allows one to dene the location, timing and dosage of such drug delivery, thus this technique has value as an investigative tool and for addressing the progression of specic disease states. [3] [4] [5] [6] In this context, we and others have developed photo-activated NO releasing moieties (photoNORMs), since triggering with light can provide precise spatial and temporal control of NO delivery. [7] [8] [9] [10] However, this methodology is limited by the strong wavelength dependence of light transmission through tissue. 11, 12 Ultraviolet and shorter visible light are much less tissue penetrating than are longer red or (ideally) near-infrared (NIR) wavelengths. The ability of NIR light to transmit deeply into tissue has inspired various approaches to designing photoNORM systems including the engineering of molecular compounds that are photoactive at longer wavelengths 13, 14 and the use of antennas for multi-photon sensitization of NO release with NIR light. [15] [16] [17] [18] However, delivering these conjugates to the desired physiological targets continues to be a challenge.
It is difficult to deliver the desired drug payload specically to hypoxic areas of tumors via simple diffusion from the blood stream, owing to poorly developed vascular structures.
from the blood via chemotaxis, that once inside the tumor differentiate into macrophages. 22 This behavior has stimulated interest in recruiting macrophages as carriers [23] [24] [25] [26] [27] [28] to localize drugs in tumors at levels difficult to attain with conventional delivery methods.
The present study demonstrates the utility of macrophages as carriers of micron-sized, poly(lactic-co-glycolic acid) (PLGA) microparticles in which one can incorporate a theranostic payload. The encapsulated payload here includes a photoNORM that can be triggered for NO release by NIR light together with Nd 3+ doped upconverting nanoparticles (Nd-UCNPs) to provide imaging capabilities. 29, 30 The BALB/c bone marrow derived macrophages (BMMs) were shown to undergo phagocytosis of these microcarriers. Such macrophages allow far deeper penetration into large NIH-3T3/4T1 co-cultured tumor spheroids (Scheme 1) than do the microparticles alone. Thus, as previously described by Clare and coworkers, 23 such macrophages have the potential to act as "cellular Trojan Horses" to carry a therapeutic payload into tumors. It is shown here that, once carried inside the spheroid by a BMM, the photoNORM in the microparticles can be activated with NIR light to release NO. At high light intensity, NO concentrations sufficient to cause direct tumor cell cytotoxicity are generated, while at low light intensity, the NO released leads to a signicant drop in the expression of hypoxia inducible factor HIF-1a in the tumor microenvironment.
Results and discussion

NIR active photoNORM and Nd-UCNPs in microparticles
The cell-mediated delivery platform described here consisted of murine BMMs loaded with polymer-based microcarriers into which were incorporated a NIR sensitive photoNORM and NIR active bioimaging Nd-UCNPs. The photoNORM was prepared by metathesis of the water-soluble salt [Mn(dpaq NO 2 )(NO)]ClO 4 (dpaq NO 2 ¼ 2-[N,N-bis(pyridine-2-yl-methyl)]-amino-N 0 -5-nitroquin-olin-8-yl-acetamido) 13 with sodium tetraphenylborate to give the corresponding, hydrophobic photoNORM [Mn(dpaq NO2 )(NO)]BPh 4 (I). The hydrophobicity was needed to minimize leakage of I from the polymer microcarrier into the medium. The BPh 4 À salt was further puried by recrystallization to obtain black needles. Fig. 1 (top) shows the spectrum of I in acetonitrile. Although the l max of the longest wavelength band is $650 nm, this absorbance extends to the NIR region (3: 20.2 M À1 cm À1 at 794 nm) and overlaps with the output from a 794 nm diode laser used as a continuous wave (CW) excitation source in the present study. Direct 794 nm photolysis of I in acetonitrile solution does indeed lead to NO release as measured using the Sievers Nitric Oxide Analyzer (NOA) with a quantum yield of 0.18 (ESI Fig. S1 †) . The Nd-UCNPs were high quality core/shell upconverting nanoparticles (Fig. 1, bottom) synthesized using the robotic Workstation for Automated Nanocrystal Discovery and Analysis (WANDA) of the Molecular Foundry at Lawrence Berkeley National Laboratory. [31] [32] [33] The host material for the 10 nm
Scheme 1 Illustration of macrophage cellular Trojan Horse strategy to carry polymer based microparticles containing a photochemical precursor of NO (photoNORM) plus upconverting nanoparticles (UCNPs) into a tumor. NIR activation of the photoNORM/UCNP combination releases NO to mediate the tumor environment in order to facilitate various types of therapy as well as providing the opportunity for photoluminescence imaging. 
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The energy from multiple photons is transferred sequentially from the excited Yb 3+ dopants to Tm 3+ emitters, thereby producing upconverted photoluminescence (PL) bands in the UV and visible range. The transmission electron microcopy (TEM) and PL spectra of these Nd-UCNPs are shown in Fig. 1 (bottom).
The polymer-based microcarriers were prepared from PLGA dissolved in dichloromethane (DCM) by a micro-emulsion technique as described previously 37, 38 and in the Experimental methods section (see below). The procedure simultaneously encapsulated the photoNORM I and/or Nd-UCNPs into spherical PLGA particles with ca. 1-micron diameter (0.35-2 mm) (ESI Fig. S2 & S3 †) . The average loading of the manganese photo-NORM was 4.36 AE 0.66 wt% as determined by inductively coupled plasma atomic emission spectroscopy (ICP-AES). The spherical micro-particles have the optimal shape to facilitate phagocytosis. 39 The PLGA was acid terminated and the resulting surface carboxylates were modied with immunoglobulin G (IgG) by amide coupling in 0.1 M pH 5.5 2-(N-morpholino) ethanesulfonic acid (MES) buffer to increase the efficiency of phagocytosis. A bicinchoninic acid (BCA) protein assay indicated there is ca. 44 mg of IgG per mg of PLGA particles.
NO release from photoNORM loaded polymer microparticles
Previous studies in these laboratories 16, 40 have shown that UCNPs can serve as photosensitizers that absorb NIR photons and emit visible light to trigger NO release from photoNORMs that were not NIR sensitive. This process requires relatively high intensity irradiation to effect the multi-photon upconversion mechanism of UCNPs and energy transfer from UCNPs to photoNORMs. In the present case, the Mn photoNORM I is photosensitive toward NO release via direct single-photon excitation with 794 nm light, and this allows one to overcome the scattering constraints that may be problematic for multiphoton excitation in deeper tissue. However, since the extinction coefficient for I at this wavelength is low (20 
was of interest to see whether the visible light generated by upconversion from the Nd-UCNP would enhance NO release owing to the signicantly higher extinction coefficients of I in the visible spectral region. In order to test this possibility, microparticles of two different compositions were prepared. One contained both I and Nd-UCNPs (PLGA-1), the other contained only the manganese photoNORM I (PLGA-2). Data obtained from dynamic light scattering (DLS) showed these two particle groups to be similar in average size ($1 micron, ESI Fig. S2 † top) , while ICP-AES analysis showed the former to have somewhat higher loading of I (4.76 wt% vs. 3.79 wt% respectively). Particles of both types (0.5 mg) were separately suspended in 2.5 mL pH 7.4 phosphate buffered saline (PBS) solution and were irradiated with a 794 nm diode laser while stirring and purging with medical grade air. The purge gas was analyzed for NO using the NOA for 1.0 s irradiation times at different intensities (in W cm À2 
Microparticle uptake and compatibility
The goal of these experiments was to determine the amount of loaded PLGA microparticles that can undergo phagocytosis into the murine bone marrow macrophages that had been prepared as described in the Experimental section (see ESI †). It has been previously shown that rigid spheres, 1-3 microns in diameter, are readily taken up by this mechanism. 27, 41, 42 As noted above, said microparticles were also surface modied with a covalently bound layer of IgG to enhance uptake (ESI Fig. S4 † ). An alamarBlue® cell viability assay was used to determine whether the microparticles proved toxic to the BMM cells. Fig. 3 shows that these particles displayed no signicant acute toxicity for concentrations as high as 100 mg mL À1 for incubation periods of 
Intracellular NO release
BMMs loaded with microparticles containing both I and NdUCNPs (BMMp + ) were then tested to verify internal release of NO. The reporter was 4-amino-5-methylamino-2 0 ,7 0 -diuoro-uorescein diacetate (DAF-FM), which reacts to form a uores-cent compound when exposed to intracellular NO. DAF-FM was incubated with the BMMp + macrophages and a control set of BMMs without microparticles. Prior to DAF-FM incubation, both sets were treated with L-N-nitroarginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, to reduce background from biological NO production. 44 Upon 794 nm laser exposure at 13.0 W cm À2 for 90 s, the BMMp + set clearly produced a visible uorescence response while the BMM set without particles did not (ESI Fig. S5 †) .
Microparticle effects on macrophage chemotaxis
The ability of macrophages to target tissue such as tumors is governed by their ability to undergo chemotaxis towards sites of inammation. 22 Thus, it is crucial that the macrophages retain this function aer drug loading. This question was probed using a transendothelial assay (ESI Fig. S6 †) . First, monolayers of bEnd.3 blood brain barrier (BBB) endothelial cells were grown on FluoroBlok™ transwell inserts inside of the wells of a 24-well plate as model endothelium barriers. Such monolayers are very tight compared to those from other endothelial cells, thereby making migration through the barrier challenging. although in the latter case an even sharper drop in chemotaxis was observed. However, there are various strategies that can be used to enhance overall macrophage recruitment and therapeutic efficacy, if needed.
28,46,47
Tumor spheroid penetration
In order to model a 3D tumor environment, tumor spheroids were prepared from co-cultured murine NIH/3T3 broblast: 4T1 breast cancer cells with a 5 : 1 cell seeding ratio similar to that used previously. 48 Incorporation of broblasts into tumor spheroids induces formation of a tumor stroma which enhances spheroid compactness and increases the expression of pro-inammatory cytokines used in leukocyte chemotaxis. Pimonidazole (PIMO) staining of the spheroids revealed hypoxia throughout the spheroid interior. Considering that hypoxia normally occurs 100-150 mm into a tumor, 50 this is not surprising. Macrophages labeled with Celltracker™ deep red were used to monitor the chemotactic penetration of the BMMp + cells into spheroids. Images of tumor spheroid center slices indicated deep penetration (Fig. 3b) Fig. S9 †) . Assuming that the BMMp + retained their payload at the concentration shown by ICP, these macrophages brought an estimated 8.7 AE 6.6 pico-equivalents of the photoNORM into the spheroid. The value of the macrophages as "Trojan Horses" was demonstrated using particles labeled with uorescent IgG. Spheroid slices (Fig. 3c ) demonstrated that macrophages with internalized uorescent particles carried their payload into the spheroids (Fig. 3c ) but that IgG modied microparticles alone were unable to penetrate more than a few cell layers when incubated with the spheroids (Fig. 3d ).
Nd-UCNP imaging
The Nd-UCNPs introduced to the polymer-based microparticles provide an imaging agent that allows one to track the location of these prodrug carriers and their macrophage hosts using tissuepenetrating NIR excitation wavelengths. In addition, since their chemotactic capacities allow macrophages to hone in on inammation sites, the PL from UCNPs provides a potential mechanism to detect hidden metastatic sites. Since I is photoactivated by the same NIR wavelength, the combination of this photoNORM and Nd-UCNP in these macrophage-carried microparticles would provide theranostic capability. principle with regard to using UCNPs to track the macrophages, but it is clear that either more efficient emitters or (given that the nonlinear relationship between UCNP PL and excitation intensities) a more intense laser source may be needed for in vivo diagnostic applications. On-going studies will address this issue.
Photoactivated NO release inside spheroids
The next question was whether NO released by NIR excitation of these BMMp + inltrated spheroids can be detected externally using the NOA, which to the best of our knowledge, would be unprecedented. Five spheroids incubated with BMMp + or
BMMs with PLGA-only particles (BMMp À ) were positioned in the corner of a custom designed cuvette (Fig. 5a ) containing 1 mL of Hank's Balanced Salt Solution (HBSS) solution. In typical NOA analysis, the solution is entrained with the carrier gas and stirred to facilitate transfer of NO to the detector. However, such conditions would likely cause spheroid disassembly and cell lysis. Instead, the spheroids were blanketed with unstirred HBSS solution and irradiated with the 794 nm diode laser operating at 13.1 W cm À2 for specied time periods (Fig. 5a ). Subsequent gentle bubbling with medical-grade air above the spheroids released NO from the solution without disrupting the spheroids. The procedure could be repeated several times with each sample (Fig. 5b and c) . The NO released photolysis from the ve BMMp + inltrated spheroids aer the 6 min (total) was 13.6 pmol ($2.7 pmol per spheroid (avg)). In contrast, spheroids treated with BMMp À cells gave no measurable NOA response. Based on volumes of $1 mL, NO steady state concentrations in excess of 1 mM were generated in the spheroids, a concentration exceeding that needed to induce p53 phosphorylation and/or nitrosative stress mediated apoptosis.
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The effect of generating such high localized NO concentrations was examined by evaluating cell viability aer 24 h using a p-nitrophenyl phosphate (PNPP) assay.
51 Fig. 5d illustrates the results of irradiating spheroids containing BMMp + or BMMp À cells with 794 nm light for 1 to 3 six-minute periods at 13.1 W cm À2 . In general, the data in Fig. 5d consistently show reduced cell viability for irradiated spheroids inltrated with BMMp + cells relative to those loaded with BMMP À cells, the most convincing example being the 26% reduction for spheroids containing photoNORM loaded macrophages aer 12 min irradiation compared to 6.6% reduction for similarly treated BMMp À loaded spheroids. However, the experimental uncertainties are large and barely statistically signicant owing no doubt to unavoidable variability in spheroid loadings and the difficulty in preparing, photolyzing and analyzing a statistically large number of loaded spheroids. Notably, the spheroids used in this study were formed from 4T1 breast cancer cells, which are p53 decient, 52 so the observed damage can largely be attributed to nitrosative stress induced apoptosis. Cancers with p53 pathways are likely to be more sensitive to NO delivery at these concentrations.
Low NO concentrations have been shown to produce benecial shis in tumor microenvironment through reduction of factors such as P-glycoprotein and HIF-1a that are implicated in increased resistance to chemo-and radio-therapy.
53-55 HIF1a is a transcriptional factor upregulated in hypoxia that controls the expression of genes correlated with tumor cell survival, metastasis, and angiogenesis. 56 The effect of generating lower NO concentrations on HIF-1a levels in the tumor spheroids was examined by using LED excitation (0.58 mW cm À2 at 735 nm). Aer 8.5 h exposure, the spheroids were dissociated into a single cell suspension. Cells were then xed and labeled with anti-HIF-1a and by a uorescent secondary antibody. Analysis with ow cytometry (Fig. 6 Fig. S10 †) , thus conrming the impact on this proliferative factor upon delivering a low concentration of NO.
Summary
These studies demonstrate that the timing and dosage of NO release from photoNORM loaded microparticles can be controlled inside tumor models by triggering with tissue penetrating NIR light. Bone marrow derived macrophages serve as Trojan Horse carriers for the polymer-based microparticles incorporating both the photoNORM (I) and Nd 3+ -doped upconverting nanoparticles for therapeutic and imaging applications. In this manner, the carrier macrophages load large quantities of a photoactivated therapeutic agent without signicant effects on viability. The loaded BMMp + cells maintain the chemotactic ability to traverse an in vitro brain blood barrier transendothelial model and to penetrate tumor spheroids with their photoactive cargos. Such penetration does not occur with the microparticles alone. However, while the tumor spheroids provide a valuable proof-of-principle, in vitro model to demonstrate that macrophages can inltrate and deliver a payload to such tissues, the next stage will be to demonstrate such targeting in vivo. In this context we are encouraged by a recent study 57 where blood monocytes loaded with nano-sized polymeric micelles containing paclitaxel (PTX) were used to treat metastatic breast cancer in mice. Such PTX delivery was signicantly more efficient than using free PTX or PTX loaded nanoparticles alone. Both I and the Nd-UCNPs are excited with NIR light at $800 nm, the ideal wavelength for tissue transmission. Thus, the Nd-UCNP emission is used to visualize BMMp + cells inl-trated into spheroids while NIR photoactivation of I released NO. We demonstrate two types of potentially therapeutic effects by using different light intensities to irradiate the BMMp + cell inltrated tumor spheroids. The micromolar NO concentration generated by high intensity NIR laser excitation leads to increased nitrosative stress and cell mortality. In contrast, lower concentrations of NO served to modify the tumor microenvironment by destabilizing HIF-1a. Although not explored in the current study, it should be noted that targeted NO release in the hypoxic regions of tumors should enhance the effectiveness of cancer chemotherapy 55 and radiotherapy. 58, 59 In these contexts, macrophage-mediated delivery of photoNORMs combined with NIR excitation represents a fresh approach that allows one to target tumors or other diseased tissues characterized by inammation. This strategy will facilitate the spatially and temporally controlled release of NO or of other caged compounds for precise therapeutic applications.
Experimental section
Materials
All cell lines (4T1, NIH-3T3, and bEnd.3) were purchased from ATCC. BALB/c mice (6-8 weeks old) were purchased from Charles River. Sodium tetraphenylborate, sodium triuoroacetate, sodium oleate, ammonium uoride, lanthanide chlorides (99.9+%), oleic acid (OA) (90%), 1-octadecene (ODE) (90%), poly(vinyl) alcohol (PVA, M w : 13 000-23 000), 4-morpholineethanesulfonic acid (MES, low moisture content, 99+%), immunoglobulin G (IgG from mouse serum), N-(3-dimethylaminopropyl)-N 0 -ethylcarbodiimide hydrochloride (EDC$HCl, commercial grade), Triton™ X-100 (BioXtra), Tween® 20 (BioXtra), agarose (BioReagent), sodium hydroxide (NaOH, ACS reagent grade), sodium acetate (RegentPlus®), puried human plasma bronectin (1 mg mL À1 ), and Perfecta3D® 96-well hanging drop plates were purchased from Sigma-Aldrich. 10Â PBS (OmniPur® liquid concentrate) was purchased from EMD Millipore. Poly(lactic-co-glycolic acid) (5050 DLG 8A, acid terminated) was purchased from Lakeshore Biomaterials. )(NO)] ClO 4 , (119.3 mg, 0.195 mmol) was dissolved in 3 mL solution of 1 : 1 acetonitrile/deionized (DI) water that was then added to a 2 mL volume of acetonitrile (ACN) in which was dissolved NaBPh 4 (66.7 mg, 0.195 mmol). The resulting mixture was sonicated for 3 min aer which most of the solvent was removed under reduced pressure. The resulting hydrophobic black solid was suspended in aqueous solution then collected by ltration, washed with DI water and dried under vacuum. The solid was then dissolved in dichloromethane (DCM) and recrystallized by vapor diffusion of ether to produce crystalline black needles of I.
IgG-modied microcarriers
The procedure for forming the polymer micro-emulsions was modied from the literature.
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Acid-terminated PLGA (100 mg) and $80 mL of a solution of Nd-UCNPs in hexane ($10 mg UCNPs) were added into 500 mL DCM, and the mixture was sonicated for 45 min at room temperature. A 14 mg sample of I was dissolved in a mixture of ACN (150 mL) and DCM (400 mL) to form a dark purple solution that was then transferred into the PLGA solution, and the mixture was sonicated until homogenous. If the volume of as-prepared solution was lower than 1.1 mL, more DCM was added. The polymer solution was slowly added into 200 mL of 1 wt% polyvinyl alcohol (PVA) aqueous solution contained in a 250 mL half-spherical container while the ultrasonic homogenizer was turned to 350 watts for 30 s. A dark brown colloidal solution formed immediately. The ask containing the colloidal suspension was fully covered with aluminum foil and stirred overnight to evaporate the volatile organic solvents. The milky solution was centrifuged to collect a solid, which was washed with 18 megohm pure water to remove the PVA. Following particle purication, the brown pellet was re-suspended in 45 mL pure water and then the 1-micron particles were separated by different centrifuge speed (4000 rpm to remove particles <500 nm and 300 rpm to remove particles size >3 mm). The resulting particles were dried under vacuum and re-suspended in 0.1 M pH 5.5 MES buffer solution with the concentration of 1 mg mL À1 . EDC$HCl (70.94 mmol per 1 mg particles) and NHS (106.87 mmol per 1 mg particles) were added into the colloidal MES solution, which was then sonicated at room temperature for 30 min. Subsequently, 10 mL IgG solution (11.21 mg mL À1 ) per 1 mg microparticles was added and the mixture stirred overnight. The IgG modied particles were collected by centrifugation and washed with 18 megohm pure water at least three times. IgG concentration was determined with a micro BCA assay according to the manufacturer's instructions. Aer incubation, particles were removed from solution with centrifugation to avoid light scattering during absorbance measurements. Initially, a beaker was utilized during the emulsion process, however; better yields were obtained using a half-spherical glass ash, since there are no corners in the latter and the sonic energy is distributed equally preventing settling and allowing more of the PLGA to form particles of the correct size.
Bone marrow macrophage preparation and other cell cultures
Bone marrow was harvested from 6-8 week old BALB/c mice in accordance with previously published methods.
60 Experiments were performed in compliance with all United States federal and California state regulations governing the humane care and use of laboratory animals, including the USDA Animal Welfare Act (Registration #: 93-R-0438) and the PHS Policy on Humane Care and Use of Laboratory Animals (PHS Assurance # A3865-01) and were reviewed and approved by the University of California Santa Barbara Institutional Animal Care and Use Committee as part of protocol 6-16-916. Aer marrow isolation, cells were then suspended in a 90% FBS/10% dimethyl sulfoxide (DMSO) and frozen for later use according to previous reports.
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Unless otherwise specied, all culture ware used with macrophages was non-TC treated plastic. Bone marrow macrophages were produced via slight modication of previously published methods.
60 Cryo-preserved bone marrow was thawed and added to 10 mL of DMEM/F-12 media supplemented with 10 mM GlutaMAX™, 10% FBS, 1000 U mL À1 P/S, and 20 ng mL À1 MCSF-1 (media denoted as DMEMb) cells were centrifuged at 400 g for 10 min, resuspended in DMEMb at 2.3 Â 10 6 live cells per mL.
DMEMb (24 mL) and 1 mL of bone marrow were added to a ask and put in the incubator for 7-8 days to allow the bone marrow to mature into BMMs. On day 3, 25 mL of additional DMEMb was added to each ask to replenish the MCSF-1 in solution. Aer cells had matured into BMMs, DMEMb was removed from the ask and cells were washed with DPBS. To dislodge the cells, the ask was treated with ice cold Accumax™ (10-15 mL) for 20-30 min, and thumped once with the palm of the hand. Cells were collected, washed with DMEMb and centrifuged at 400 g for 10 min. Cells were resuspended in Bambanker™ cell cryopreservation media at 5 Â 10 6 cells per mL. BMMs were kept at À80 C overnight and were transferred to liquid nitrogen aer-wards. Conrmation of macrophage maturation was done using CD11b staining as described by Zhang et al.
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For experiments, BMMs were thawed and added to non-TC treated dishes for 24 h. Cells were then detached with Accumax™ and counted. These cells were then replated at 62 500 BMM per cm 2 on plastic ware 18 h prior to the experiment.
NIH-3T3 murine broblast cells, 4T1 murine breast cancer cells, and bEnd.3 murine brain endothelial cells between passage 3-15 were cultured on TC-treated plastic ware with Dulbecco's modied eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1000 U mL À1 of penicillin/ streptomycin (P/S) and 1 mM sodium pyruvate (media mixture known as DMEMpy). Cells were passaged with 0.25% trypsin/ EDTA once they reached a conuency of >80%.
Tumor spheroids
Tumor spheroids were grown with a procedure based on previous research. 48 Conuent plates of 4T1 and NIH-3T3 cells were split and resuspended in DMEMpy and then mixed at a ratio of 1 : 5 4T1 : NIH-3T3 at a total cell concentration of 1.11 Â 10 4 cells per mL. To prevent evaporation of the hanging drops, the liquid reservoirs on 96 well hanging drop plates from 3d Biomatrix were lled with hot 0.5% w/v agarose and allowed to cool to room temperature. A 45 mL aliquot of the cell mixture was added to the top of each well. Plates were sealed with Paralm® and put in the cell incubator for 7 days. Media was replenished on days 4 and 6 by removing 15 mL of media from each droplet and adding 15 mL of fresh DMEMpy. This procedure was done 2 times in a row during each media change instead of removing 30 mL of media all at once which can compromise the droplet. Spheroids were grown in droplets for 7 days. To incorporate macrophages, spheroids were transferred into 200 mL 96 well PCR plates used to allow for their easy manipulation and inversion on the rotisserie without spilling. Spheroids were washed 3 times with 100 mL of DMEMpy. DMEMpy (50 mL) was added to each spheroid aer the nal wash. A 50 mL aliquot of a solution of BMMs with blank or NOdonor loaded particles at 4 Â 10 5 cells per mL in DMEMpy was added to each spheroid. Plates were put on a rotisserie in a cell incubator for 3 days to assure optimal interaction between macrophages and spheroids. On day 1.5, 100 mL of additional DMEMpy was added to each spheroid to replenish solution nutrients. Aer 3 days, spheroids were washed 3 times with DMEMpy to remove macrophages that had failed to inltrate the spheroid. Spheroids were then used for various downstream applications.
Particle loading into BMMs
Particles with or without NO-donor and UCNPs in DI water at a concentration of 5 mg mL À1 in a glass vial were sonicated for 10 min to break up particle aggregates. A volume of 340 mL of the microparticle solution was added to macrophages plated at 62 500 cells per cm 2 in a 100 mm diameter non-TC treated Petri dish in 17 mL of DMEMb to make a 100 mg mL À1 solution.
Dishes were put in a culture incubator for 2 h to allow for phagocytosis. Cells were washed once with warm DPBS aer which, ice cold Accumax™ (5 mL) was added and incubated at 37 C for 15-30 min. Cells were then pipetted up and down gently to release them from the plate. DMEMb (5-7 mL) was added to the cell suspension. Cells were centrifuged once at 400 g for 10 min and resuspended in 2 mL DMEMb. Cells were then centrifuged 3 times at 42 g for 5 min to remove free particles in solution. In cases where macrophage tracking was desired, 2 mM CellTracker™ deep red in serum free DMEMb was added to cells for 45 min before Accumax™ was applied.
Quantication of particle loading and macrophage uptake
Particles of a known concentration containing the NO-donor and UCNPs were digested in 1 : 3 HNO 3 : HCl for 24 h to assure all manganese was completely dissolved. Inductively coupled plasma atomic emission spectroscopy (ICP-AES) was conducted with a Thermo iCAP 6300 and was used to measure the manganese content of each sample. Samples were compared to manganese standard. For quantication of particle uptake, 3 Â 10 6 cells with particles were analyzed in the same manner. These cells were compared to cells without particles.
Macrophage-particle compatibility
Macrophages loaded with microparticles as described above with various particle incubation concentrations were plated at 62 500 cells per cm 2 in 96 well plates in 100 mL DMEMb. Cells were put in a cell incubator and le for 24 or 48 h. A mixture containing 100 mL of DMEMb and 20 mL of alamarBlue® was added to the media in each well. The plate was incubated for 3.5 h. A volume of 110 mL of each well was transferred to black bottomed well plates to improve the sensitivity of the uores-cence measurement. Solution uorescence was measured on a TECAN M220 Innite Pro plate reader (l ex ¼ 550 nm, l em ¼ 590 nm). Fluorescence from wells without cells was subtracted as baseline.
Qualitative determination of NO release
Human bronectin at 150 mg mL À1 in DPBS was added to glass confocal dishes and incubated for 2 h at 37 C to improve its cell adhesion properties. Wells were washed 3 times with DPBS. Macrophages with particles were plated in the glass confocal dishes at 62 500 cells per cm 2 and incubated for 8 h in DMEMpy. Cells were incubated with L-NAME at 75 mg mL À1 in
DMEMpy for 1 h to inhibit biological NO production from nitric oxide synthases. Wells were aspirated and 9.3 mM 4-amino-5-methylamino-2 0 ,7 0 -diuorourescein (DAF-FM-2DA), a dye that detects intracellular NO release, with L-NAME in DMEMpy was added to the cells and incubated for 1 h. Wells were washed ve times with phenol red free, FBS free DMEMpy with L-NAME to remove uninternalized DAF-FM. Wells were exposed to a 794 nm laser for 90 s at 13.1 W cm À2 . NucBlue® was added to the wells to label cell nuclei. Wells were imaged 20 min later. Images were taken with an Olympus Fluoview 1000 Spectral Confocal. Care was taken to image cells as quickly as possible to prevent the release of extra NO. Samples were compared to macrophages exposed to the laser without particles.
Quantication of macrophage chemotaxis
Human bronectin (50 mL, 150 mg mL À1 ) in DPBS was added to the top of 24-well sized FluoroBlok™ transwell inserts with 8 mm pores and incubated in a cell incubator for 1.5-2 h to improve their adhesion properties for endothelial cells. The top of the inserts was washed 3 times with 200 mL of DMEMpy. A 200 mL aliquot of bEnd.3 cells at a concentration of 1 Â 10 5 cells per mL were added to the top of each well. Cells were incubated for 4.5 days with media changes every other day. No media was added to the bottom of the insert until the nal day to prevent the growth of a monolayer in the bottom of the insert which has been reported previously when media is added to both sides. 62 On day 4.5, media in the top insert was replaced and 600 mL of DMEMpy was added to the bottom of the insert. Transepithelial electrical resistance (TEER) values were taken and all inserts with a value $0.33 U cm 2 , which traditionally represents a fully conuent monolayer, were accepted for the experiment. Inserts were washed 3 times with DMEMpy. 200 mL of either DMEMpy alone, or BMMs with or without particles at 5 Â 10 5 cells per mL in DMEMpy were added to the top of the inserts and 600 mL of DMEMpy with 125 ng mL À1 MCP-1 was added to the bottom of each well to serve as a chemoattractant for the macrophages. Cells were incubated for 24 h in a cell incubator and washed once with DPBS. NucBlue® in HBSS was added to the top and bottom of each insert to visualize cells. Aer 20 min, images from 3 random locations from the bottom of each insert were taken with an Olympus CKX-41 inverted microscope. Cells were counted with the particle analysis tool on ImageJ. Wells that contained only a bEnd.3 monolayer were used as a baseline and were subtracted out of macrophage wells.
Determination of macrophage/spheroid penetration
Macrophages labeled with CellTracker™ deep red were allowed to penetrate spheroids as described above to allow for visualization. Spheroids were xed in ice-cold methanol for 30 min. Spheroids were then embedded in Tissue-Tek® O. C. T. compound and sectioned with a 25 mm thickness. Spheroids were mounted with Vectashield® hard set mounting media with 4,6-diamidino-2-phenylindole (DAPI) to preserve samples and stain cell nuclei. For hypoxia detection, some spheroids were incubated with 100 mM PIMO in DMEMpy for 2 h prior to xa-tion with methanol (MeOH). This allowed PIMO to fully inl-trate spheroids and covalently bind to cells in hypoxic regions. Aer sectioning, these samples were blocked with PBS containing 4% FBS, 1% goat serum, and 0.05% Tween® 20 (blocking solution) for 1 h. Hypoxyprobe Red549 (#HP7-100Kit; Hypoxyprobe) in a 1 : 200 dilution in blocking solution was added to each spheroid for 18 h at 4 C to allow the antibody to bind to the PIMO present in the sectioned spheroid. Sections were then washed three times with PBS with 0.05% Tween® 20.
In other experiments to demonstrate retention of particles aer spheroid penetration, particles were labeled with Cy3.5®-IgG. Because of the overlap between Hypoxyprobe Red549 and Cy3.5®, they were not used together. Images were acquired with an Olympus Fluoview 1000 spectral confocal microscope and processed with ImageJ.
NO release measurement
The NO measurement followed the modied procedure from the literature. 16 All spheroids were carefully transferred to 1 mL HBSS solution in a modied cuvette and closely placed at the corner in order to get full exposure with a 794 nm diode laser.
Medical-grade air was purged into the cuvette through plastic tubing but not directly purged into the solution. Laser intensity 13.1 W cm À2 was applied to all spheroid-involved measurement.
During the period of laser irradiation on these spheroids, the medical air purging was only above the solution. But once the irradiation was stopped, the purging tubing was manually immersed into the solution carefully in order to avoid agitating these spheroids. The owing gas conveyed the NO released to the NOA.
Confocal imaging of UCNPs in live tumor spheroids
Spheroids were grown and incubated with macrophages with and without particles as described in a previous section. Calcein AM (10 mM) was incubated with the spheroids for 2 h in DMEMpy and to mark spheroid peripheries. Live spheroids were added to a Petri dish with HBSS. UCNPs were detected using a 3 W 100 fs pulsed laser (37.5 nJ per pulse) operating at 810 nm. Images were acquired with an Olympus Flowview 1000MPE confocal microscope with a 25Â objective (numerical aperture ¼ 1.05). Images were recorded over a 508.431 mm Â 508.431 mm area (1024 Â 1024 pixels) and were acquired with a scan rate of 100 ms per pixel. Bandpass lters (420-460 nm and 495-540) nm were utilized to isolate uorescence from UCNPs and calcein AM, respectively. Images acquired every 10 mm were combined to form 3D reconstructions with ImageJ.
Tumoricidal potential of high dose NO therapy
Five spheroids containing microparticle loaded macrophages with and without NO-donor were transferred to the corner of a cuvette containing DMEMpy. Spheroids were exposed to a 794 nm laser at 13.1 W cm À2 for 6 min to release NO from particles inside macrophages in the spheroids. This procedure was done to each spheroid 1, 2, or 3 times with 2 min between each exposure. The spheroids were transferred to a 96 TCtreated well plate and incubated for 24 h. Aer incubation, media was removed and 100 mL of DPBS was added to each well. To measure spheroid viability, a PNPP assay was used as previously described with slight modications. 51 Briey, one 10 mg PNPP substrate tablet was added to 5 mL of a solution containing 0.1 M sodium acetate and 0.1% Triton™ X-100. A 100 mL aliquot of this solution was added to the DPBS already in each well. The plate was incubated at 37 C for 3-3.5 h. NaOH (10 mL, 1 M) was added to each well aer which absorbance was measured at 405 nm on a TECAN M220 Innite Pro plate reader within 10 min of NaOH addition to prevent loss of signal.
Tumor microenvironment modulation with low dose NO therapy
Spheroids with particle loaded macrophages were transferred to a 96 well TC-treated plate with a pipette and were incubated for 12 h to allow them to adhere. Half of the spheroids were then exposed to a 735 nm LED at 0.58 mW cm À2 for 8.5 h. Spheroids were collected in groups of 6 and washed once with DPBS. Accumax™ (300 mL) was added and spheroids were incubated for 30-45 min. Spheroids were broken up with rapid pipetting to form a single cell suspension. Cells were xed with 4% paraformaldehyde (PFA) for 10 min followed by permeabilization with ice cold methanol (MeOH) for 10 min to allow for antibody labeling. Cells were washed three times with DPBS with 1% BSA and 0.1% Tween 20. Rabbit anti-HIF-1a (1 : 100, #PA1-16601; ThermoFisher Scientic) in 1% w/v BSA and 0.1% Tween 20 was added to the cells for 1 h at RT. Cells were washed once with DPBS with 1% BSA and 0.1% Tween 20. FITC labeled goat-anti-rabbit IgG (H + L) (1 : 250, #A27034; ThermoFisher Scientic) was added to the cells for 30 min in DPBS with 1% BSA and 0.1% Tween 20. Cells were washed with DPBS 3 times and analyzed via ow cytometry on a FACSAria (Becton Dickinson) using 488 nm (HIF-1a) or 633 nm (CellTracker Deep Red) excitation. Cells were analyzed for % of the cells with uores-cence signal greater than background by setting the gate to exclude the signal from unstained cells (negative control).
Results were analyzed with FCM Express 6 Plus.
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